Literature DB >> 33673020

Toxic Animal-Based Medicinal Materials Can Be Effective in Treating Endometriosis: A Scoping Review.

Su-In Hwang1, Young-Jin Yoon1,2, Soo-Hyun Sung3, Ki-Tae Ha4, Jang-Kyung Park1,2.   

Abstract

Animal toxins and venoms have recently been developed as cancer treatments possessing tumor cell growth-inhibitory, antiangiogenesis, and proapoptotic effects. Endometriosis is a common benign gynecological disorder in reproductive-age women, and no definite treatment for this disorder is without severe side effects. As endometriosis and malignant tumors share similar characteristics (progressive, invasive, estrogen-dependent growth, and recurrence), animal toxins and venoms are thought to be effective against endometriosis. The objective of this study was to outline studies using toxic animal-based medicinal materials (TMM) as endometriosis treatment and to explore its clinical applicability. Preclinical and clinical studies using TMM were searched for in four databases from inception to October 2020. A total of 20 studies of TMM on endometriosis were included. In eight clinical studies, herbal medicines containing TMM were effective in relieving symptoms of endometriosis, with no side effects. In twelve experimental studies, the main therapeutic mechanisms of TMM against endometriosis were proapoptotic, antiangiogenesis, estrogen level-reducing, and possible anti-inflammatory effects. TMM are thus considered promising sources for the development of an effective treatment method for endometriosis. Further studies are needed to clarify the therapeutic mechanism of TMM against endometriosis and to provide sufficient grounds for clinical application.

Entities:  

Keywords:  Eupolyphaga; Hirudo; Scolopendra; Scorpio; endometriosis; toxic animal-based medicinal materials

Mesh:

Substances:

Year:  2021        PMID: 33673020      PMCID: PMC7917649          DOI: 10.3390/toxins13020145

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  53 in total

1.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

2.  World Endometriosis Society consensus on the classification of endometriosis.

Authors:  Neil P Johnson; Lone Hummelshoj; G David Adamson; Jörg Keckstein; Hugh S Taylor; Mauricio S Abrao; Deborah Bush; Ludwig Kiesel; Rulla Tamimi; Kathy L Sharpe-Timms; Luk Rombauts; Linda C Giudice
Journal:  Hum Reprod       Date:  2016-12-05       Impact factor: 6.918

Review 3.  Endometriosis.

Authors:  Krina T Zondervan; Christian M Becker; Kaori Koga; Stacey A Missmer; Robert N Taylor; Paola Viganò
Journal:  Nat Rev Dis Primers       Date:  2018-07-19       Impact factor: 52.329

Review 4.  Clinical Management of Endometriosis.

Authors:  Tommaso Falcone; Rebecca Flyckt
Journal:  Obstet Gynecol       Date:  2018-03       Impact factor: 7.661

5.  [Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].

Authors:  Lin Liu; Bao-an Chen; Shu-kui Qin
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2011-01

6.  Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Authors:  Yi-Quan Yan; Juan Xie; Jing-Fu Wang; Zhao-Feng Shi; Xiang Zhang; Yong-Ping Du; Xing-Cheng Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-27

Review 7.  Hemocoagulase agkistrodon-induced anaphylactic shock: A case report and literature review.

Authors:  Yan-Yan Xu; Xu-Hui Ma; Shao-Jun Zhang
Journal:  Int J Clin Pharmacol Ther       Date:  2016-02       Impact factor: 1.366

Review 8.  Medicinal leech therapy-an overall perspective.

Authors:  Ali K Sig; Mustafa Guney; Aylin Uskudar Guclu; Erkan Ozmen
Journal:  Integr Med Res       Date:  2017-08-10

9.  Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial.

Authors:  Liling Zeng; Guanghai Tang; Jing Wang; Jianbin Zhong; Zhangyong Xia; Jiexia Li; Guangsheng Chen; Yongbo Zhang; Saihua Luo; Gan Huang; Qianshan Zhao; Yue Wan; Chaojun Chen; Kaiyun Zhu; Hanzi Qiao; Jian Wang; Tao Huang; Xian Liu; Qixin Zhang; Rongming Lin; Haijun Li; Baoying Gong; Xiuyan Chen; Yuexiang Zhou; Zehuai Wen; Jianwen Guo
Journal:  BMJ Open       Date:  2019-05-09       Impact factor: 2.692

10.  Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer.

Authors:  Ying Wang; Kai Li; Song Han; Yi-Hao Tian; Peng-Chao Hu; Xiao-Long Xu; Yan-Qi He; Wen-Ting Pan; Yang Gao; Zun Zhang; Jing-Wei Zhang; Lei Wei
Journal:  Cancer Med       Date:  2019-02-25       Impact factor: 4.452

View more
  2 in total

1.  Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.

Authors:  Xujun You; Yongrong Wu; Qixin Li; Wen Sheng; Qing Zhou; Wei Fu
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

2.  Drug Development Using Natural Toxins.

Authors:  Gihyun Lee
Journal:  Toxins (Basel)       Date:  2021-06-11       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.